1. Investing in late-stage clinical trials and manufacturing of product candidates for five major infectious diseases: a modelling study of the benefits and costs of investment in three middle-income countries. Issue 7 (July 2022) Authors: Schäferhoff, Marco; Zimmerman, Armand; Diab, Mohamed M; Mao, Wenhui; Chowdhary, Vipul; Gill, Davinder; Karanja, Robert; Madikizela, Mziwandile; Ogbuoji, Osondu; Yamey, Gavin Journal: Lancet Issue: Volume 10:Issue 7(2022) Page Start: e1045 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗